These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 20840836)
1. Efficacy of combination immunotherapy of IgM MAb B6.1 and amphotericin B against disseminated candidiasis. Han Y Int Immunopharmacol; 2010 Dec; 10(12):1526-31. PubMed ID: 20840836 [TBL] [Abstract][Full Text] [Related]
2. Combination immunotherapy of MAb B6.1 with fluconazole augments therapeutic effect to disseminated candidiasis. Lee JH; Jang EC; Han Y Arch Pharm Res; 2011 Mar; 34(3):399-405. PubMed ID: 21547671 [TBL] [Abstract][Full Text] [Related]
3. Synergic effect of grape seed extract with amphotericin B against disseminated candidiasis due to Candida albicans. Han Y Phytomedicine; 2007 Nov; 14(11):733-8. PubMed ID: 17913484 [TBL] [Abstract][Full Text] [Related]
4. Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody. Han Y; Riesselman MH; Cutler JE Infect Immun; 2000 Mar; 68(3):1649-54. PubMed ID: 10678984 [TBL] [Abstract][Full Text] [Related]
5. Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits. Deren YT; Ozdek S; Kalkanci A; Akyürek N; Hasanreisoğlu B Can J Microbiol; 2010 Jan; 56(1):1-7. PubMed ID: 20130687 [TBL] [Abstract][Full Text] [Related]
6. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin. Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150 [TBL] [Abstract][Full Text] [Related]
7. Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans. An M; Shen H; Cao Y; Zhang J; Cai Y; Wang R; Jiang Y Int J Antimicrob Agents; 2009 Mar; 33(3):258-63. PubMed ID: 19095412 [TBL] [Abstract][Full Text] [Related]
8. Liquiritigenin, a licorice flavonoid, helps mice resist disseminated candidiasis due to Candida albicans by Th1 immune response, whereas liquiritin, its glycoside form, does not. Lee JY; Lee JH; Park JH; Kim SY; Choi JY; Lee SH; Kim YS; Kang SS; Jang EC; Han Y Int Immunopharmacol; 2009 May; 9(5):632-8. PubMed ID: 19264152 [TBL] [Abstract][Full Text] [Related]
9. Host immune reactivity determines the efficacy of combination immunotherapy and antifungal chemotherapy in candidiasis. Mencacci A; Cenci E; Bacci A; Bistoni F; Romani L J Infect Dis; 2000 Feb; 181(2):686-94. PubMed ID: 10669356 [TBL] [Abstract][Full Text] [Related]
10. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis. Warn PA; Sharp A; Morrissey G; Denning DW J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462 [TBL] [Abstract][Full Text] [Related]
11. Synergic anticandidal effect of epigallocatechin-O-gallate combined with amphotericin B in a murine model of disseminated candidiasis and its anticandidal mechanism. Han Y Biol Pharm Bull; 2007 Sep; 30(9):1693-6. PubMed ID: 17827722 [TBL] [Abstract][Full Text] [Related]
12. Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis. Xin H; Rosario-Colon JA; Eberle K mSphere; 2023 Feb; 8(1):e0058422. PubMed ID: 36688668 [TBL] [Abstract][Full Text] [Related]
13. Alternative dosing regimens of liposomal amphotericin B (AmBisome) effective in treating murine systemic candidiasis. Adler-Moore JP; Olson JA; Proffitt RT J Antimicrob Chemother; 2004 Dec; 54(6):1096-102. PubMed ID: 15509617 [TBL] [Abstract][Full Text] [Related]
14. Combined antifungal therapy in a murine infection by Candida glabrata. Mariné M; Serena C; Pastor FJ; Guarro J J Antimicrob Chemother; 2006 Dec; 58(6):1295-8. PubMed ID: 17012301 [TBL] [Abstract][Full Text] [Related]
15. Effect of mycolase and amphotericin B on Candida albicans and Candida pseudotropicalis in vitro and in vivo. Chalkley LJ; Trinci AP; Pope AM Sabouraudia; 1985 Jun; 23(3):147-64. PubMed ID: 3895468 [TBL] [Abstract][Full Text] [Related]
16. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model. Khan MA; Owais M J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592 [TBL] [Abstract][Full Text] [Related]
17. Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus. Warn PA; Sharp A; Morrissey G; Denning DW Int J Antimicrob Agents; 2010 Feb; 35(2):146-51. PubMed ID: 20015618 [TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model. Andes D; Stamsted T; Conklin R Antimicrob Agents Chemother; 2001 Mar; 45(3):922-6. PubMed ID: 11181381 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of alternative dosing regimens of poly-aggregated amphotericin B. Espada R; Valdespina S; Molero G; Dea MA; Ballesteros MP; Torrado JJ Int J Antimicrob Agents; 2008 Jul; 32(1):55-61. PubMed ID: 18534826 [TBL] [Abstract][Full Text] [Related]
20. Tolerance to amphotericin B in clinical isolates of Candida tropicalis. Barchiesi F; Maracci M; Baldassarri I; Spreghini E; Giannini D; Scalise G Diagn Microbiol Infect Dis; 2004 Nov; 50(3):179-85. PubMed ID: 15541603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]